Subcutaneous immunoglobulin (SCIg) for primary and secondary immunodeficiencies
We developed our first SCIg to treat primary immunodeficiencies4 and some secondary immunodeficiencies. It’s administered under the skin for a more convenient dosing option and faster infusion than intravenous administration, enhancing patients’ treatment alternatives.